Transfusion Alternatives

Journal of Infusion Nursing

Volumn 26, Issue 1, 2003, Pages 29-33

  Rudnicke, Cheryl ^a  

^a Visiting Health Professionals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; BLOOD SUBSTITUTE;

ANEMIA; BLEEDING; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD DONOR; BLOOD SUBSTITUTION; COLLOID; CRYSTALLOID; HEMATOPOIETIC SYSTEM; HUMAN; MEDICINE; PRIORITY JOURNAL; RELIGION; REVIEW; SAFETY; SCREENING TEST; TREATMENT INDICATION; VASCULARIZATION; BLOOD TRANSFUSION; FORECASTING; INFECTION CONTROL; METHODOLOGY; TREATMENT REFUSAL;

BLOOD SUBSTITUTES; BLOOD TRANSFUSION; FORECASTING; HUMANS; INFECTION CONTROL; RELIGION AND MEDICINE; SAFETY MANAGEMENT; TREATMENT REFUSAL;

EID: 0037270347     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200301000-00004     Document Type: Review

References (15)

1. America's Blood Center medical information. Quick blood facts 2001.
2. American Association of Blood Banks. All About Blood: Facts About Blood and Blood Banking. September 1999.
3. Blood transfusions: sustaining the purpose of god. Watchman Expositor. 1991;8(9).
4. The Watchtower Society's new policy on blood transfusions. Watchman Expositor. 2000.
5. Health and Sciences Television Network. Transfusion and other cultures. EDA 230-0352.
6. Blood transfusion and blood substitutes. Presented at the Fifth Toronto Critical Care Medicine Symposium; October 26, 2000; Toronto.
7. Robb WJW. Searching for an ideal blood substitute. RN. 1998;61(8):26.
8. th Congress of the European Society for Medical Oncology; October 13, 2000.
9. Physician's Desk Reference. 2002.
10. Long acting form of erythropoietin boosts blood hemoglobin. Blood Weekly. May 17, 2001:8.
11. American Red Cross. Plasma Technology Center. About Plas+SD. 2001.
12. Clark C. Recombinant hemoglobin safely used in hemodilution. Blood Weekly. Sept 16, 1996:2.
13. Alliance Pharmaceutical Corporation. Oxygent fact sheet. 2002.
14. Biopure claims safety success for Hemopure's Phase II trial [Biopure press release]. Boston Business Journal. August 27, 2001.
15. Webb IJ. Risks, costs, and alternative to platelet transfusion. Leukemia & Lymphoma. 1999;34(1/2):71.